Compare · MAIN vs SFE
MAIN vs SFE
Side-by-side comparison of Main Street Capital Corporation (MAIN) and Safeguard Scientifics Inc. (SFE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MAIN and SFE operate in Finance/Investors Services (Finance), so they compete in similar markets.
- MAIN carries a market cap of $5.29B.
- MAIN has hit the wire 27 times in the past 4 weeks while SFE has been quiet.
- MAIN has more recent analyst coverage (13 ratings vs 0 for SFE).
Main Street Capital Corporation
Main Street Capital Corporation is a private equity firm specializes in equity capital to lower middle market companies. The firm also provides debt capital to middle market companies for acquisitions, management buyouts, growth financings, recapitalizations and refinancing. The firm seeks to partner with entrepreneurs, business owners and management teams and generally provides "one stop" financing alternatives within its lower middle market portfolio. The firm typically invests in lower middle market companies generally with annual revenues between $10 million and $150 million. The firm's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. It makes majority and minority equity investments. Main Street Capital Corporation was founded in 2007 and is based in Houston, Texas.
Safeguard Scientifics Inc.
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.
Latest MAIN
- PRESIDENT, CIO AND SMD Magdol David L. acquired $7,076 worth of shares (131 units at $54.10), increasing direct ownership by 0.03% to 441,468 units (SEC Form 4)
- Director Jackson John Earl acquired $19,272 worth of shares (357 units at $54.06), increasing direct ownership by 0.40% to 86,866 units (SEC Form 4)
- Director Lane Brian E. acquired $14,132 worth of shares (261 units at $54.06), increasing direct ownership by 0.49% to 54,120 units (SEC Form 4)
- Director Foster Vincent D acquired $83,323 worth of shares (1,557 units at $53.50), increasing direct ownership by 0.07% to 1,681,318 units (SEC Form 4)
- VP, CAO & Assistant Treasurer Mchugh Ryan acquired $4,759 worth of shares (89 units at $53.50), increasing direct ownership by 0.39% to 22,985 units (SEC Form 4)
- Director Solcher Stephen B acquired $11,081 worth of shares (204 units at $54.27), increasing direct ownership by 0.38% to 53,439 units (SEC Form 4)
- Director Shive Dunia A acquired $5,793 worth of shares (107 units at $54.27), increasing direct ownership by 0.38% to 27,909 units (SEC Form 4)
- Director Griffin Jon Kevin acquired $15,008 worth of shares (277 units at $54.21), increasing direct ownership by 0.37% to 75,761 units (SEC Form 4)
- CEO, SMD Hyzak Dwayne L. acquired $24,436 worth of shares (457 units at $53.50), increasing direct ownership by 0.09% to 510,067 units (SEC Form 4)
- EVP, GC, SECRETARY Beauvais Jason B acquired $5,906 worth of shares (110 units at $53.50), increasing direct ownership by 0.06% to 196,837 units (SEC Form 4)
Latest SFE
- SEC Form 15-12G filed by Safeguard Scientifics Inc.
- SEC Form SC 13E3/A filed by Safeguard Scientifics Inc. (Amendment)
- SEC Form EFFECT filed by Safeguard Scientifics Inc.
- SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)
- SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)
- SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)
- Safeguard Scientifics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form POS AM filed by Safeguard Scientifics Inc.
- SEC Form S-8 POS filed by Safeguard Scientifics Inc.
- SEC Form S-8 POS filed by Safeguard Scientifics Inc.